by neuroviapeptides | Aug 10, 2026 | Longevity & Regenerative Research, Research
Glow Is Not a Metric in Peptide Research A photograph can suggest a visible glow, but it cannot establish what changed, why it changed, or whether the observation can be reproduced. For laboratory researchers evaluating peptide-related aesthetic or longevity pathways,...
by neuroviapeptides | Aug 8, 2026 | Research, Research Fundamentals
Are Peptides FDA Approved? The Research Reality A peptide’s molecular identity does not determine its FDA status. The intended use, finished dosage form, labeling, manufacturing controls, clinical evidence, and marketing claims determine the regulatory pathway. That...
by neuroviapeptides | Aug 8, 2026 | Cognitive & Neurological Research, Research, Research Fundamentals
NAD+: Research Priorities for Quality and Control NAD+ is often discussed as a longevity-related molecule, but the laboratory question is more exacting: what material is being measured, under what conditions, and how confidently can the result be reproduced? For...
by neuroviapeptides | Aug 7, 2026 | Research, Research Fundamentals
How to Qualify Peptide Vendors for Research A peptide that arrives with a stated purity but no batch-level evidence creates an avoidable variable in an analytical workflow. Knowing how to qualify peptide vendors means looking beyond a catalog claim and determining...
by neuroviapeptides | Aug 6, 2026 | Research
BAM15 in Mitochondrial Uncoupling Research Mitochondrial uncoupling experiments can become difficult to interpret long before data analysis begins. A small shift in cell density, substrate availability, solvent exposure, or assay timing may alter the apparent...
